[1. Vlahović-Palcevski V, Morović M, Palcevski G, Betica-Radić L. Antimicrobial utilization and bacterial resistance at three different hospitals. Eur J Epidemiol. 2001; 17(4): 375-83.10.1023/A:1012742314070]Search in Google Scholar
[2. Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother. 2007; 51(3): 864-7.10.1128/AAC.00994-06180310617210766]Search in Google Scholar
[3. Raymond DP, Pelletier SJ, Sawyer RG. Antibiotic utilization strategies to limit antimicrobial resistance. Semin Respir Crit Care Med 2002; 23(5): 497–501.10.1055/s-2002-3572116088644]Search in Google Scholar
[4. Urbánek K, Kolár M, Strojil J, Koukalová D, Cekanová L, Hejnar P. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidemiol Drug Saf. 2005; 14(10): 741-5.10.1002/pds.111015880441]Search in Google Scholar
[5. Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P; PEP and PEAP-study investigators; Board of the European Society of Infections in Urology. Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents. 2006; 28: S91-107.10.1016/j.ijantimicag.2006.05.00516829052]Search in Google Scholar
[6. Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P, van Ostrum E, Bjerklund, Johansen T. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol. 2013. Epub ahead of print10.1007/s00345-013-1154-823979151]Search in Google Scholar
[7. Medina-Polo J, Jiménez-Alcaide E, García-González L, Guerrero-Ramos F, Pérez-Cadavid S, Arrébola-Pajares A, Sopeña-Sutil R, Benítez-Salas R, Díaz-González R, Tejido-Sánchez A. Healthcare-associated infections in a department of urology: Incidence and patterns of antibiotic resistance. Scand J Urol. 2013. Epub ahead of print10.3109/21681805.2013.83451224344974]Search in Google Scholar
[8. World Health Organization Collaborating Centre for Drug Statistics Methodology. About the ATC/DDD system. (Available at: http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf Accessed 1.12. 2013).]Search in Google Scholar
[9. Pešić G, Jović Z, Vasić K. Primena ATC/DDD metodologije pri upoređivanju upotrebe antibiotika u toku dvomesečnog perioda u dvema hirurškim bolnicama. Acta Facultatis Medicae Naissensis. 2006; 23(1): 39-44.]Search in Google Scholar
[10. Radonjić V, Đukić L, Stefanović D, Tešić D. Promet i potrošnja antibiotika u Republici Srbiji. Arhiv za farmaciju. 2007; 57(4-5): 332-46.]Search in Google Scholar
[11. Bulajić S, Hadžistević S, Milovanović D, Trajković G, Vujačić N, Stanojević Z. Upotreba antibiotika za sistemsku primenu u hirurškoj klinici KBC-Priština u Gračanici. Praxis medica. 2011; 39(1-2): 17-22.]Search in Google Scholar
[12. Veliĉković-Radovanović R, Petrović J, Kocić B, Antić S, Randelović G. Correlation between antibiotic consumption and bacterial resistance as quality indicator of proper use of these drugs in inpatients. Vojnosanit Pregl. 2009; 66(4): 307-12.10.2298/VSP0904307V]Search in Google Scholar
[13. Pavlović R, Janković S, Đorđević Z. Profile of urinary tract infections pathogens and their antimicrobial resistance patterns during three-year period (2009-2011) in the Clinical center Kragujevac. Racionalna terapija 2013; 5(2): 27-41.10.5937/racter5-3385]Search in Google Scholar
[14. Ghadiri H, Vaez H, Khosravi S, Soleymani E. The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections. Crit Care Res Pract. 2012; 2012: 890797.10.1155/2012/890797353074923304471]Search in Google Scholar
[15. Van der Donk CF, Beisser PS, Hoogkamp-Korstanje JA, Bruggeman CA, Stobberingh EE; Antibiotic Resistance Surveillance Group. A 12 year (1998-2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals. J Antimicrob Chemother. 2011; 66(4): 855-8.10.1093/jac/dkq53821393165]Search in Google Scholar
[16. Zilberberg MD, Chen J, Mody SH, Ramsey AM, Shorr AF. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med 2010; 10: 45.10.1186/1471-2466-10-45293958120796312]Search in Google Scholar
[17. Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, Kim M. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2010; 31(1): 47-53.10.1086/64902119951202]Search in Google Scholar
[18. Master RN, Clark RB, Karlowsky JA, Ramirez J, Bordon JM. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Int J Antimicrob Agents. 2011; 38(4): 291-5.10.1016/j.ijantimicag.2011.04.02221737249]Search in Google Scholar
[19. Jankovic S. Rational Use Of Antibiotics In Clinical Practice. Racionalna terapija 2009; 1(1): 1-6.10.5937/racter8-9663]Search in Google Scholar